Loading headlines…

Collected headline brief
A clinical trial testing the weight-loss drug Wegovy on children aged six to 12 has found that 40.4 percent of those given the treatment were no longer classified as obese after 68 weeks.
There is more to this story
Complete reading on newsGlobal
Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →